ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 5: Heart Failure - Left ventricular dysfunction
Tue 30 Aug 08:30 - 12:30 Pharmacologic therapy Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
08:30P4369Impact of levosimendan treatment, in acute heart failure patients, on mortality and re-hospitalization rate: a long term follow-upNoemi BRUNO (Rome, IT)
08:30P4370VE/VCO2 slope: What is the most powerful independent predictor of survival: overall, initial or final VE/VCO2 slopes? A study in 786 consecutive patients with left ventricular systolic dysfunctionAurelie MUSSCHOOT (Lille, FR)
08:30P4371Selective HDL raising gene transfer increases survival, attenuates remodeling, and enhances cardiac function following myocardial infarction in mice Stephanie GORDTS (Leuven, BE)
08:30P4372How valid are the european society of cardiology echocardiographic diastolic criteria in diagnosing heart failure with normal ejection fraction?Gnanadevan MAHADAVAN (Adelaide, AU)
08:30P4373Acute benefical impact of adaptive servo ventilation on hemodynamic data in heart failure patients with Cheyne-Stokes respirationMakiko MIYATA (Fukushima, JP)
08:30P4374Physical exercise attenuates diabetes-induced left ventricular and myocardial dysfunction in ratsCamila GIMENES (Pederneiras, BR)
08:30P4375Remodelling of left ventricular mechanic in dilated cardiomyopathy: a two-dimensional speckle tracking echocardiography study.Bjoern GOEBEL (Jena, DE)
08:30P4376Evidence for impaired left ventricular contractility during normal pregnancyMette-Elise ESTENSEN (Oslo, NO)
08:30P4377Cavopulmonary shunt after LVAD implantation improves haemodynamics in patients having relatively impaired right heart: an in-silico analysisShuji SHIMIZU (Osaka, JP)
08:30P4378Effects of intraaortic balloon pump counterpulsation on left ventricular systolic and diastolic function in a porcine model of acute ischemic heart failure;differences between ischemia and reperfusionIoannis TERROVITIS (Athens, GR)
08:30P4379Hyperdehydroepiandrosterone in hemodynamically instable neonates with refractory hypotensionTo Be Announced
08:30P4380Alterations in ventriculo-arterial coupling and systemic arterial properties during normal pregnancyMette-Elise ESTENSEN (Oslo, NO)
08:30P4381Diagnostic value of Doppler transthoracic echocardiography in the estimation of left ventricular filling pressure in patients with severe symptomatic systolic heart failureBarnabas GELLEN (Creteil, FR)
08:30P4382Assessment of right ventricular regional and global function in asymptomatic patients with repaired tetralogy of Fallot by ultrasound speckle tracking imagingMingxing XIE (Wuhan, CN)
08:30P4383Non invasive hemodynamic evaluation of patients with acute heart failure in emergency department: impedance cardiography compared with clinical evaluation and B type Natriuretic Peptide (BNP) .Marcelo MONTERA (Rio De Janeiro, BR)
08:30P4384Aortic stiffness and left atrial volume index in adult dialyzed patients: dependence - compliance and pressureAndrzej WYSOKINSKI (Lublin, PL)
08:30P4385Pressure volume relationship is related to coronary flow reserve in non-ischemic dilated cardiomyopathyQuirino CIAMPI (Benevento, IT)
08:30P4386Obese heart failure patients have less cardiac impairment than thinner counterpartsLip-Bun TAN (Leeds, GB)
08:30P4387Determinants of right ventricular mass in heart failure patients with reduced ejection fraction: A MRI based study Julia VORMBROCK (Herne, DE)
08:30P4388Invasive evaluation of whether decline in pressure after initial immediate increment on improving AV delay of CRT is due to vasodilatation or decline in cardiac functionPunam Ashok PABARI (London, GB)
08:30P4389Impact the transcatheter aortica valve implantation in patients with severe aortic stenosis with reduced left ventricular ejection fractionAntonio Jesus MUNOZ GARCIA (Malaga, ES)
08:30P4390Evaluation of systolic-diastolic left ventricular function in competitive athletes: study by two-bidimensional speckle trackingKetty SAVINO (Perugia, IT)
08:30P4391Chronic GLP-1 treatment preserves diastolic function and improves survival in rats with pressure overloadTorsten DOENST (Jena, DE)
08:30P4392Inhibition of ASK1 attenuates angiotensin II- or TGFbeta-stimulated cardiomyocyte hypertrophy and fibroblast collagen synthesis: therapeutic potential of ASK1 inhibitors in myocardial remodellingBing WANG (Melbourne, AU)
08:30P4393Asymptomatic left ventricular systolic dysfunction is prevalent and undertreated prior to diagnosis: a report from the STOP - HF studyGillian MURTAGH (Mullingar, IE)
08:30P4394Levosimendan as a weaning strategy from inotropesFranck SIBELLAS (Lyon, FR)
08:30P4395Lung impedance guided preemptive treatment of evolving acute heart failure in course of acute myocardial infarction reduces use of furosemide.Avraham SHOTAN (Hadera, IL)
08:30P4396Natriuretic peptide inhibition in the presence of angiotensin receptor blockade following short-term treatment with LCZ696 in heart failure patients: effect on ANP, BNP, NT-proBNP and cGMP.Zhanna D KOBALAVA (Moscow, RU)
08:30P4397Insulin treatment retards post-ischemic heart failure by inhibition of myocardial CaMKII via PI3K-Akt activation in ratsFeng GAO (Xi'an, CN)
08:30P4398Excessive extracellular matrix metabolism identify a sub-group of post-myocardial infarction patients with preserved left ventricular dysfunction who may benefit from eplerenone Dimitrios N TZIAKAS (Alexandroupolis, GR)
08:30P4399Efficacy and safety of recombinant human Atrial Natriuretic Peptide ( rhANP) for acute decompensated heart failure: a multicenter randomized controlled dose-finding studyGuogan WANG (Beijing, CN)
08:30P4400Low-dose of beta-blocker in combination with milrinone improves cardiac function in patients with acute decompensated heart failureShigeki KOBAYASHI (Ube, JP)
08:30P4401The differences of hemodynamic response between nicorandil and carperitide in patients with acute decompensated heart failureHidetoshi HATTORI (Izumiku Yokohama, JP)
08:30P4402Administration of the cyclic peptide COR-1 in humans neutralizes anti-beta1 receptor-antibodies, but does not induce other immune effectsMartin UNGERER (Planegg/Martinsried, DE)
08:30P4403Ivabradin compare with bisoprolol reduces segmental diastolic dysfunction and improves diastolic functional reserve in patients with diastolic heart failure.To Be Announced
08:30P44043',4'-dihydroxyflavonol (DIOHF) attenuates diastolic dysfunction and cardiac remodelling in streptozotocin-induced diabetic m(Ren2)27 ratsFay Lin KHONG (Fitzroy, AU)
08:30P4405Effects of aliskiren on Left ventricular remodeling in patients with dilated cardiomyopathyHiroshi SAKAI (Otsu, JP)
08:30P4406When conventional heart failure therapy is not enough: angiotensin receptor blocker or aldosterone antagonist?Sripal BANGALORE (New York, US)
08:30P4407Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with chronic heart failureYulia ZABOLOTNEVA (Moscow, RU)
08:30P4408Evaluating the trial strategy for dosage application of betablockers and their impact on the quality of life using the minnesota living with heart failure questionnaire (mlhfq)Domingos MELO (Jaboatao Dos Guararapes, BR)
08:30P4409Clinic blood pressure in stable heart failure patients treated with the dual-acting neprilysin and angiotensin receptor inhibitor LCZ696Yulia KOTOVSKAYA (Moscow, RU)
08:30P4410Optimum or maximum, that is the question: a retrospective analysis of pharmacological therapy achieved in a hospital based, nurse led heart failure clinicAbdallah AL-MOHAMMAD (Barnsley, GB)
08:30P4411Influence of eplerenone treatment on the number of endothelial progenitor cells in patients with chronic heart failureChristian JUNG (Jena, DE)
08:30P4412Renal effects of a novel dual acting V1a/V2 vasopressin receptor antagonist: comparison with furosemidePeter KOLKHOF (Wuppertal, DE)
08:30P4413Alternate anticoagulation with the parenteral anti-Xa agent otamaxiban in heparin compromised conditionsIndermohan THETHI (Maywood, US)
08:30P4414Dose titration of the oral potassium binder RLY5016 to maintain normal serum potassium in heart failure and chronic kidney disease patients on aldosterone antagonistsBertram PITT (Ann Arbor, US)
08:30P4415Evidence of altered isovolumic contraction during diastolic dysfunction with preserved ejection fraction in chronic hypertensive pigs.Bijan GHALEH (Creteil, FR)
08:30P4416Assessment of both time-left atrial volume curve and left atrial emptying function by speckle tracking echocardiography is useful to evaluate left ventricular diastolic function in elderly patients Takatomo WATANABE (Gifu Pref., JP)
08:30P4417Albumin levels predict survival in patients with heart failure with normal ejection fractionMing LIU (Shatin,N.T., HK)
08:30P4418Chronic inhibition of protein tyrosine phosphatase 1B improves diastolic function and limits endothelial dysfunction in insulin resistant / obese miceElodie GOMEZ (Rouen, FR)
08:30P4419Impact of left ventricular diastolic dysfunction on screening for left ventricular systolic dysfunction using b-type natriuretic peptide: a report from the STOP - HF study Gillian MURTAGH (Mullingar, IE)
08:30P4420Assessment of single ventricle diastolic function during stress echocardiography in adult patients after fontan operationLidia TOMKIEWICZ-PAJAK (Krakow, PL)
08:30P4421Prevalence of diastolic left ventricular dysfunction in european populations based on cross-validated diagnostic thresholds.Katarzyna STOLARZ-SKRZYPEK (Krakow, PL)
08:30P4422Myeloperoxidase is critically linked to the development of diastolic heart failure following pressure overloadFlorian DEUSCHL (Hamburg, DE)
08:30P4423SERCA2a gene transfer improves diastolic function in ischemic heart failureTo Be Announced
08:30P4424Angiotensin II-induced diastolic dysfunction is associated with cardiac inflammation and peripheral monocytosis.Jedrzej HOFFMANN (Bad Nauheim, DE)